TY  - JOUR 
AU  - Gómez-Reino Carnota, Juan Jesús
PY  - 2012
SN  - 0004-3591
UR  - http://hdl.handle.net/20.500.11940/4707
LA  - eng
TI  - A Phase IIb Dose-Ranging Study of the Oral JAK Inhibitor Tofacitinib (CP-690,550) Versus Placebo in Combination With Background Methotrexate in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate Alone
DO  - 10.1002/art.33419
T2  - ARTHRITIS AND RHEUMATISM
M2  - 970
VL  - 64
ER  -